Tesaro Company Profile (NASDAQ:TSRO)

About Tesaro

Tesaro logoTESARO, Inc. is an oncology-focused biopharmaceutical company. The Company acquires, in-licenses and develops oncology product candidates. It operates in business of developing and commercializing oncology-focused therapeutics segment. It has in-licensed and are developing oncology-related product candidates, including intravenous (IV) rolapitant and niraparib, as well as product candidates under its immuno-oncology platform. It offers VARUBI (rolapitant), which is an oral substance P/neurokinin 1 (NK-1) receptor antagonist for use in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy. It is developing IV formulation of rolapitant, which has completed various Phase 1 clinical trials. Its niraparib is an orally active and poly (ADP-ribose) polymerase (PARP) inhibitor. Its immuno-oncology platform has immuno-oncology programs, which include TSR-022 and TSR-042.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: TSRO
  • CUSIP: 88156910
Key Metrics:
  • Previous Close: $108.04
  • 50 Day Moving Average: $94.58
  • 200 Day Moving Average: $65.54
  • 52-Week Range: $29.51 - $110.48
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -17.71
  • P/E Growth: -0.68
  • Market Cap: $5.55B
  • Outstanding Shares: 51,365,000
  • Beta: 1.66
  • Net Margins: -783.97%
  • Return on Equity: -205.63%
  • Return on Assets: -91.81%
  • Debt-to-Equity Ratio: 0.75%
  • Current Ratio: 5.63%
  • Quick Ratio: 5.49%
Additional Links:
Companies Related to Tesaro:

Analyst Ratings

Consensus Ratings for Tesaro (NASDAQ:TSRO) (?)
Ratings Breakdown: 2 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $98.05 (9.25% downside)

Analysts' Ratings History for Tesaro (NASDAQ:TSRO)
DateFirmActionRatingPrice TargetDetails
9/14/2016SunTrust Banks Inc.Reiterated RatingBuy$91.60View Rating Details
9/13/2016FBR & CoReiterated RatingBuyView Rating Details
9/6/2016Lake Street CapitalReiterated RatingBuy$114.00View Rating Details
8/30/2016Bank of America Corp.Initiated CoverageNeutral$97.00View Rating Details
8/25/2016Leerink SwannReiterated RatingOutperform$108.00View Rating Details
8/24/2016RBC Capital MarketsReiterated RatingOutperform$122.00View Rating Details
8/12/2016Royal Bank Of CanadaInitiated CoverageOutperform$122.00View Rating Details
8/8/2016Citigroup Inc.Boost Price TargetBuy$90.00 -> $120.00View Rating Details
8/5/2016Credit Suisse Group AGReiterated RatingBuyView Rating Details
8/5/2016Jefferies GroupSet Price TargetHold$75.00 -> $80.00View Rating Details
8/5/2016WedbushReiterated RatingBuyView Rating Details
8/5/2016MizuhoLower Price TargetBuy$100.00 -> $94.00View Rating Details
7/18/2016Robert W. BairdInitiated CoverageOutperform$105.00View Rating Details
6/30/2016Wells Fargo & Co.Reiterated RatingOutperformView Rating Details
8/31/2015Raymond James Financial Inc.Initiated CoverageStrong-Buy$70.00View Rating Details
10/2/2014GuggenheimInitiated CoverageBuy$46.00View Rating Details
(Data available from 9/27/2014 forward)


Earnings History for Tesaro (NASDAQ:TSRO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q2($1.71)($1.28)$4.98 million$36.60 millionViewN/AView Earnings Details
5/5/2016Q1($1.69)($2.22)$2.48 million$0.31 millionViewN/AView Earnings Details
2/25/2016Q4($1.63)($1.89)$3.45 million$0.23 millionViewListenView Earnings Details
10/29/2015Q315($1.52)($1.66)ViewListenView Earnings Details
8/6/2015Q215($1.14)($1.51)ViewListenView Earnings Details
4/30/2015Q115($1.12)($1.30)ViewListenView Earnings Details
2/19/2015Q414($1.03)($1.33)ViewListenView Earnings Details
11/5/2014Q314($1.04)($1.01)ViewN/AView Earnings Details
7/24/2014Q214($0.87)($1.03)ViewN/AView Earnings Details
4/30/2014Q114($1.06)($1.43)ViewN/AView Earnings Details
2/19/2014Q413($0.78)($0.72)ViewN/AView Earnings Details
11/7/2013Q313($0.69)($0.88)ViewN/AView Earnings Details
7/25/2013Q2 2013($0.63)($0.67)ViewN/AView Earnings Details
4/25/2013Q1 2013($0.62)($0.66)ViewN/AView Earnings Details
2/14/2013Q4 2012($0.65)($15.41)ViewN/AView Earnings Details
10/25/2012($0.55)($0.52)ViewN/AView Earnings Details
7/26/2012($0.55)($4.11)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Tesaro (NASDAQ:TSRO)
Current Year EPS Consensus Estimate: $-7.36 EPS
Next Year EPS Consensus Estimate: $-6.10 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($1.69)($1.59)($1.64)
Q2 20162($1.69)($1.58)($1.64)
Q3 20164($1.80)($1.49)($1.66)
Q4 20164($1.84)($1.54)($1.67)
(Data provided by Zacks Investment Research)


Dividend History for Tesaro (NASDAQ:TSRO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Tesaro (NASDAQ:TSRO)
Insider Ownership Percentage: 40.50%
Institutional Ownership Percentage: 88.81%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/22/2016Martin H Jr. HuberSVPSell408$108.12$44,112.96View SEC Filing  
9/8/2016Edward C EnglishVPSell7,000$88.54$619,780.00View SEC Filing  
8/30/2016Jeffrey H HankeVPSell29,166$86.04$2,509,442.64View SEC Filing  
6/30/2016Jeffrey H HankeVPSell12,500$74.35$929,375.00View SEC Filing  
6/10/2016Edward C EnglishVPSell7,000$40.75$285,250.00View SEC Filing  
3/18/2016Arnold L OronskyDirectorBuy142,085$35.19$4,999,971.15View SEC Filing  
3/18/2016Enterprise Associates 13 L NewMajor ShareholderBuy710,429$35.19$24,999,996.51View SEC Filing  
3/10/2016Edward C EnglishVPSell7,000$43.71$305,970.00View SEC Filing  
12/10/2015Edward C. EnglishVPSell17,000$50.19$853,230.00View SEC Filing  
9/8/2015James O ArmitageDirectorBuy500$54.63$27,315.00View SEC Filing  
12/12/2014James O ArmitageDirectorBuy1,000$38.16$38,160.00View SEC Filing  
9/29/2014Lawrence M AllevaDirectorBuy1,100$26.17$28,787.00View SEC Filing  
7/31/2013Lawrence M AllevaDirectorBuy1,449$34.33$49,744.17View SEC Filing  
6/5/2013Peter J BarrisMajor ShareholderSell3,583$39.00$139,737.00View SEC Filing  
4/30/2013Lawrence M AllevaDirectorBuy1,050$28.10$29,505.00View SEC Filing  
11/1/2012Lawrence M AllevaDirectorBuy3,240$15.45$50,058.00View SEC Filing  
8/30/2012Leon O Moulder JrCEOBuy10,000$11.69$116,900.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Tesaro (NASDAQ:TSRO)
4-traders.com logoTESARO : Announces Participation at Four Investor Conferences (NASDAQ:TSRO)
www.4-traders.com - September 24 at 6:56 PM
News IconEarnings Preview: Tesaro, Inc. (NASDAQ:TSRO) moved down 8 times out of last 15 quarters - The Independent Republic (NASDAQ:TSRO)
theindependentrepublic.com - September 22 at 7:26 PM
News IconActive biotech company shares in the news: Tesaro, Inc. (NASDAQ:TSRO), Ultragenyx Pharmaceutical Inc. (NASDAQ ... - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - September 21 at 7:17 PM
News IconHot Biotech Stocks Recap: Tesaro, Inc. (NASDAQ:TSRO), bluebird ... - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - September 20 at 4:59 PM
News IconNews review of 2 biotech stocks: Tesaro, Inc. (NASDAQ:TSRO), Puma Biotechnology, Inc. (NYSE:PBYI) - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - September 20 at 4:59 PM
News IconBiotech stocks for your portfolio: Rexahn Pharmaceuticals, Inc. (RNN ... - The Independent Republic (NASDAQ:TSRO)
theindependentrepublic.com - September 20 at 8:22 AM
marketnewsvideo.com logoNotable Friday Option Activity: SLCA, ALNY, TSRO (NASDAQ:TSRO)
www.marketnewsvideo.com - September 16 at 7:29 PM
finance.yahoo.com logoTesaro Gets Fast Track Designation for Ovarian Cancer Drug (NASDAQ:TSRO)
finance.yahoo.com - September 14 at 12:08 PM
schaeffersresearch.com logoCan TESARO Inc (TSRO) Live Up to Options Traders' Expectations? (NASDAQ:TSRO)
www.schaeffersresearch.com - September 14 at 12:08 PM
News IconLooking Ahead To The Potentially Game Changing TESARO Inc (TSRO) Data (NASDAQ:TSRO)
feedproxy.google.com - September 14 at 9:50 AM
News IconStock Trading Above Moving Averages: Tesaro, Inc. (NASDAQ:TSRO) - Post News (NASDAQ:TSRO)
www.kentuckypostnews.com - September 13 at 8:50 AM
schaeffersresearch.com logoCan TESARO Inc (TSRO) Live Up to Options Traders' Expectations? - Schaeffers Research (blog) (NASDAQ:TSRO)
www.schaeffersresearch.com - September 12 at 7:18 PM
capitalcube.com logoTESARO, Inc. – Value Analysis (NASDAQ:TSRO) : September 12, 2016 (NASDAQ:TSRO)
www.capitalcube.com - September 12 at 7:18 PM
streetinsider.com logoTESARO (TSRO) Announces Receipt of FDA Fast-Track Designation for Niraparib - StreetInsider.com (NASDAQ:TSRO)
www.streetinsider.com - September 12 at 8:51 AM
publicnow.com logoTESARO Receives FDA Fast Track Designation for Niraparib and Initiates Rolling NDA Submission (NASDAQ:TSRO)
www.publicnow.com - September 12 at 8:51 AM
nasdaq.com logoNotable Thursday Option Activity: TSRO, TSCO, PCYG (NASDAQ:TSRO)
www.nasdaq.com - September 10 at 8:44 AM
News IconTrading the Biotech News: XOMA Corporation (NASDAQ:XOMA ... - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - September 9 at 7:25 PM
News IconStock Showing Gains in Afternoon Trading: Tesaro, Inc. (NASDAQ:TSRO) - National Daily Press (NASDAQ:TSRO)
www.nationaldailypress.com - September 9 at 8:35 AM
capitalcube.com logoTESARO, Inc. breached its 50 day moving average in a Bullish Manner : TSRO-US : September 9, 2016 (NASDAQ:TSRO)
www.capitalcube.com - September 9 at 8:35 AM
News IconHC Stocks Reports= Merck & Co., Inc. (NYSE:MRK), TESARO Inc ... - share market updates (press release) (NASDAQ:TSRO)
sharemarketupdates.com - September 8 at 7:28 PM
rttnews.com logoTesaro Inc. (TSRO) Has Spiked To The Upside (NASDAQ:TSRO)
www.rttnews.com - September 8 at 11:43 AM
News IconActive biotech company shares in the news: Tesaro, Inc. (NASDAQ:TSRO), Raptor Pharmaceuticals Corp. (NASDAQ ... - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - September 7 at 11:38 AM
News IconTesaro Inc. (NASDAQ: TSRO) Stock Rating Reiterated at Lake Street Capital - BNB Daily (blog) (NASDAQ:TSRO)
www.baseball-news-blog.com - September 7 at 11:38 AM
finance.yahoo.com logoLake Street Says Buy-Rated Tesaro Holds An Attractive Portfolio Of Cancer Therapies (NASDAQ:TSRO)
finance.yahoo.com - September 6 at 7:53 PM
finance.yahoo.com logoTESARO Announces Six Data Presentations at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting (NASDAQ:TSRO)
finance.yahoo.com - September 6 at 8:42 AM
realistinvestor.com logoTESARO, Inc. (NASDAQ:TSRO)'s Growth Forecast - RealistInvestor.com (NASDAQ:TSRO)
www.realistinvestor.com - September 4 at 8:52 AM
News IconHot Biotech Stocks Recap: Tesaro (NASDAQ:TSRO), CEL-SCI (NYSEMKT:CVM) - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - August 25 at 8:50 AM
thecountrycaller.com logoTESARO Inc (TSRO) Stock Has Over 31% Upside Potential: RBC Capital - TCC (NASDAQ:TSRO)
www.thecountrycaller.com - August 24 at 7:41 PM
publicnow.com logoTESARO Announces Participation at Four Investor Conferences (NASDAQ:TSRO)
www.publicnow.com - August 24 at 7:41 PM
thecountrycaller.com logoTESARO Inc (TSRO) Stock Has Over 31% Upside Potential: RBC Capital (NASDAQ:TSRO)
www.thecountrycaller.com - August 24 at 10:57 AM
News IconHow Analysts & Retail Investors Perceive TESARO, Inc. (NASDAQ:TSRO) Shares - Post News (NASDAQ:TSRO)
www.kentuckypostnews.com - August 23 at 8:02 PM
News IconNews review of 2 biotech stocks: Tesaro, Inc. (NASDAQ:TSRO), Eleven Biotherapeutics, Inc. (NASDAQ:EBIO) - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - August 23 at 12:26 PM
nasdaq.com logoNoteworthy Monday Option Activity: TSRO, WDAY, IPGP (NASDAQ:TSRO)
www.nasdaq.com - August 22 at 7:47 PM
thestreet.com logoNice Recovery, But Momentum Is Missing (NASDAQ:TSRO)
realmoney.thestreet.com - August 17 at 8:14 PM
News IconHealthcare Stock Intraday Alert: Tesaro, Inc.'s (TSRO) - Hot Stocks Point (NASDAQ:TSRO)
www.hotstockspoint.com - August 15 at 8:17 PM
investornewswire.com logoEarnings Surprise In Focus: TESARO, Inc. (NASDAQ:TSRO) - Investor Newswire (NASDAQ:TSRO)
www.investornewswire.com - August 11 at 8:33 PM
finance.yahoo.com logoTESARO, INC. Financials (NASDAQ:TSRO)
finance.yahoo.com - August 11 at 8:33 PM
News IconHot Biotech Stocks Recap: Tesaro, Inc. (NASDAQ:TSRO), Cerus Corporation (NASDAQ:CERS) - The Voice Registrar (NASDAQ:TSRO)
voiceregistrar.com - August 10 at 8:35 PM
News IconPrice Target Raised at Tesaro Inc. (NASDAQ:TSRO) by Analysts at Citigroup - BNB Daily (blog) (NASDAQ:TSRO)
www.baseball-news-blog.com - August 9 at 8:16 PM
thestreet.com logoIt May Be Dull, but That's No Reason to Be Negative (NASDAQ:TSRO)
realmoney.thestreet.com - August 9 at 11:20 AM
fidaily.com logoBaird Initiates Coverage on TESARO, Inc. (TSRO) With A Rating Of "Outperform" - Finance Daily (NASDAQ:TSRO)
www.fidaily.com - August 8 at 8:08 PM
fool.com logoTesaro's Lonnie Moulder Is Catching Lightning in a Bottle (Again) (NASDAQ:TSRO)
www.fool.com - August 7 at 10:56 AM
equities.com logoTESARO Inc. (TSRO) Drops 6.01% on August 04 - Equities.com (NASDAQ:TSRO)
www.equities.com - August 6 at 7:51 PM
twst.com logoTesaro Inc.: Tesaro Announces Second-Quarter 2016 Operating Results (NASDAQ:TSRO)
www.twst.com - August 6 at 10:34 AM
fool.com logoWhy Tesaro, Inc. Vaulted 15% in July (NASDAQ:TSRO)
www.fool.com - August 6 at 10:34 AM
finance.yahoo.com logoEdited Transcript of TSRO earnings conference call or presentation 4-Aug-16 8:15pm GMT (NASDAQ:TSRO)
finance.yahoo.com - August 5 at 8:09 PM
News IconAnalyzing Analyst Recommendations: Tesaro, Inc. (NASDAQ:TSRO), The Coca-Cola Company (NYSE:KO) - TWN (NASDAQ:TSRO)
thewellesleysnews.com - August 5 at 10:59 AM
biz.yahoo.com logoTESARO, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:TSRO)
biz.yahoo.com - August 5 at 10:59 AM
sg.finance.yahoo.com logoTesaro reports 2Q loss (NASDAQ:TSRO)
sg.finance.yahoo.com - August 4 at 8:25 PM
feeds.reuters.com logoBRIEF-Tesaro posts Q2 shr loss $1.28 (NASDAQ:TSRO)
feeds.reuters.com - August 4 at 4:54 PM


Tesaro (NASDAQ:TSRO) Chart for Tuesday, September, 27, 2016

Last Updated on 9/27/2016 by MarketBeat.com Staff